As the adoption of GLP-1 receptor agonists (GLP-1 RAs) rapidly accelerates, the food and beverage industry stand at the threshold of significant transformation. These breakthrough medications are reshaping not only individual health outcomes but also consumer preferences and expectations. In response, manufacturers, product innovators, and nutrition professionals are re-examining how to support evolving dietary patterns,… Read more »
